2022
Medication Use for Obesity-Related Comorbidities After Sleeve Gastrectomy or Gastric Bypass
Howard R, Chao G, Yang J, Thumma J, Arterburn D, Telem D, Dimick J. Medication Use for Obesity-Related Comorbidities After Sleeve Gastrectomy or Gastric Bypass. JAMA Surgery 2022, 157: 248-256. PMID: 35019988, PMCID: PMC8756362, DOI: 10.1001/jamasurg.2021.6898.Peer-Reviewed Original ResearchConceptsTime of surgeryGastric bypassMedication discontinuationSleeve gastrectomyCumulative incidenceMedication useHyperlipidemia medicationsComorbidity resolutionLower incidenceCommon bariatric surgical proceduresLipid-lowering medication useComparative effectiveness research studyAdult Medicare beneficiariesDiabetes medication useAntihypertensive medication useLipid-lowering medicationsBariatric surgical proceduresSubset of patientsLong-term trialsAntihypertensive medicationsDiabetes medicationsLaparoscopic RouxBariatric surgeryPrimary outcomeMean age
2021
Patient-reported Comorbidity Assessment After Bariatric Surgery
Chao G, Bonham A, Ross R, Stricklen A, Ghaferi A. Patient-reported Comorbidity Assessment After Bariatric Surgery. Annals Of Surgery 2021, 276: e792-e797. PMID: 33914479, DOI: 10.1097/sla.0000000000004841.Peer-Reviewed Original ResearchConceptsGastroesophageal reflux diseaseObstructive sleep apneaComorbidity assessmentPostoperative questionnaireBariatric surgerySleep apneaBariatric surgery patientsMedical chart auditLong-term outcomesLong-term efficacyCross-sectional studyPostoperative comorbiditiesGastric bypassReflux diseasePatient comorbiditiesSurgery patientsSurgical patientsChart auditPatient reportsBACKGROUND DATAComorbiditiesPatientsResponse rateΚ statisticMean difference